Shots: Celltrion collaborates with the University of Oxford and University Hospitals Birmingham to study the efficacy of Remsima (CT-P13) as a potential treatment for COVID-19 UHB will test a series of new drugs in a CATALYST trial. If the CATALYST study indicates benefit CT-P13 it would then be assessed in larger-scale studies in one of […]Read More
